InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by LENZ BRIAN, Chief Financial Officer. Officer active across 1 companies, notably Adma Biologics, INC.. Aggregated, 7 disclosures have been recorded. Total volume traded: €52k. The latest transaction was disclosed on 11 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€70,68751,965 shares@ €1.36030.0037% mcap41.2% of flow
Common Stock
SEC:0001140361-22-019216:0·
€49,21237,178 shares@ €1.32370.0026% mcap28.7% of flow
Common Stock
SEC:0001140361-22-011251:0·
0137,500 shares0
Common Stock
SEC:0001140361-22-008673:0·
€25,83630,000 shares@ €0.86120.0013% mcap100.0% of flow
Common Stock
SEC:0001140361-21-035380·
Ideal exit: 22 Jul 2022 (T+270)
€25,83630,000 shares@ €0.86120.0013% mcap15.1% of flow
Common Stock
SEC:0001140361-21-035380:0·
Ideal exit: 22 Jul 2022 (T+270)
0495,000 shares0
Common Stock
SEC:0001140361-21-033355·
0495,000 shares0
Common Stock
SEC:0001140361-21-033355:0·
7 of 7 declarations
About LENZ BRIAN
Brian Lenz serves as the Executive Vice President and Chief Financial Officer of ADMA BIOLOGICS, INC. In this role, he is responsible for the financial management of the company, including financial planning and risk management. Brian brings expertise in finance and corporate strategy, contributing to the growth and sustainability of ADMA. His experience enables him to navigate the complex financial landscape and optimize the company's resources.
